We are live on ! Find out more
VCM

Versant Capital Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 34.21%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.66%
AUM
$1.01B
AUM Growth
+$217M
Cap. Flow
+$212M
Cap. Flow %
20.87%
Top 10 Hldgs %
33.44%
Holding
2,859
New
220
Increased
1,610
Reduced
469
Closed
82

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$57.7M
2
AVGO icon
Broadcom
AVGO
+$13.4M
3
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$10.3M
4
IWR icon
iShares Russell Mid-Cap ETF
IWR
+$9.41M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$8.7M

Top Sells

Rank Stock Value
1
GDX icon
VanEck Gold Miners ETF
GDX
+$1.27M
2
AVDE icon
Avantis International Equity ETF
AVDE
+$1.24M
3
AZN icon
AstraZeneca
AZN
+$1.1M
4
GREK
Global X MSCI Greece ETF
GREK
+$1.07M
5
HIMU
iShares High Yield Muni Active ETF
HIMU
+$779K

Sector Composition

Rank Sector Weight
1 Technology 17.87%
2 Financials 6.8%
3 Industrials 6.1%
4 Consumer Discretionary 4.96%
5 Healthcare 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOAR icon
2501
Loar Holdings
LOAR
$6.64B
$2.92K ﹤0.01%
51
-121
-70% -$8.16K
UNIT
2502
Uniti Group
UNIT
$2.32B
$2.92K ﹤0.01%
311
+304
+4,343% +$2.38K
MTDR icon
2503
Matador Resources
MTDR
$6.09B
$2.91K ﹤0.01%
46
-78
-63% -$3.91K
TFSL icon
2504
TFS Financial
TFSL
$4.93B
$2.87K ﹤0.01%
+204
New +$2.88K
UMC icon
2505
United Microelectronic
UMC
$46.9B
$2.86K ﹤0.01%
+318
New +$3.1K
PTGX icon
2506
Protagonist Therapeutics
PTGX
$9.44B
$2.85K ﹤0.01%
27
– –
AZTA icon
2507
Azenta
AZTA
$1.48B
$2.83K ﹤0.01%
134
-10,255
-99% -$306K
TRVI icon
2508
Trevi Therapeutics
TRVI
$2.64B
$2.77K ﹤0.01%
+232
New +$2.6K
HDB icon
2509
HDFC Bank
HDB
$121B
$2.74K ﹤0.01%
+110
New +$3.42K
PRCT icon
2510
Procept Biorobotics
PRCT
$1.17B
$2.73K ﹤0.01%
+109
New +$3.07K
KREF
2511
KKR Real Estate Finance Trust
KREF
$499M
$2.72K ﹤0.01%
445
-5,890
-93% -$43K
EHAB
2512
DELISTED
Enhabit
EHAB
$2.71K ﹤0.01%
192
+189
+6,300% +$2.26K
GLIBK
2513
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$958M
$2.68K ﹤0.01%
72
-3
-4% -$113
BVS icon
2514
Bioventus
BVS
$1.19B
$2.67K ﹤0.01%
+293
New +$2.46K
ORC
2515
Orchid Island Capital
ORC
$1.31B
$2.67K ﹤0.01%
380
+370
+3,700% +$2.79K
IAGG icon
2516
iShares Core International Aggregate Bond Fund
IAGG
$11.4B
$2.65K ﹤0.01%
53
+5
+10% +$251
CGON icon
2517
CG Oncology
CGON
$6.66B
$2.64K ﹤0.01%
39
– –
MED icon
2518
Medifast
MED
$141M
$2.64K ﹤0.01%
259
-1,130
-81% -$12.2K
JMIA
2519
Jumia Technologies
JMIA
$767M
$2.64K ﹤0.01%
382
– –
VRDN icon
2520
Viridian Therapeutics
VRDN
$2.67B
$2.62K ﹤0.01%
134
– –
HROW icon
2521
Harrow
HROW
$1.51B
$2.57K ﹤0.01%
73
– –
IDU icon
2522
iShares US Utilities ETF
IDU
$1.36B
$2.55K ﹤0.01%
22
– –
LXFR icon
2523
Luxfer Holdings
LXFR
$458M
$2.55K ﹤0.01%
209
– –
IMKTA icon
2524
Ingles Markets
IMKTA
$1.67B
$2.52K ﹤0.01%
28
-57
-67% -$4.62K
CTLP
2525
DELISTED
Cantaloupe
CTLP
$2.51K ﹤0.01%
+232
New +$2.45K
99 100
101
102 103

Similar funds

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 18.84% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return
EIA
Emerald Investment Advisers Leola, Pennsylvania $1.11B AUM

Versant Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Versant Capital Management held 2,859 positions worth $1.01B, up 27% from $797M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Versant Capital Management deployed $212M of net new capital in Q1 2026, opening 220 new positions and adding to 1,610 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $1.27M trimmed.

  • Versant Capital Management's largest Q1 2026 buy was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.
  • Versant Capital Management added most to Microsoft in Q1 2026, an estimated $57.7M increase.
  • Versant Capital Management's biggest Q1 2026 reduction was VanEck Gold Miners ETF, cutting an estimated $1.27M.
  • Versant Capital Management fully exited AstraZeneca in Q1 2026, selling an estimated $1.1M.
  • Versant Capital Management's ten largest holdings make up 33% of its $1.01B portfolio in Q1 2026.
  • Versant Capital Management opened 220 new positions and closed 82 in Q1 2026.
  • Versant Capital Management's portfolio value rose 27% quarter-over-quarter to $1.01B.

Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.